Pub. Date : 2014 Apr
PMID : 24668021
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Ipragliflozin has received its first global approval in this indication in Japan, for use as monotherapy or in combination with another antihyperglycaemic agent (metformin, pioglitazone, a sulfonylurea, an alpha-glucosidase inhibitor, a dipeptidylpeptidase-4 inhibitor or nateglinide). | ipragliflozin | dipeptidyl peptidase 4 | Homo sapiens |